These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 19574281

  • 21. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

  • 22. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.
    Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.
    Thyroid; 2011 Jul; 21(7):717-23. PubMed ID: 21568726
    [Abstract] [Full Text] [Related]

  • 23. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.
    Kwak JY, Kim EK, Kim JK, Han JH, Hong SW, Park TS, Choi JR.
    Head Neck; 2010 Apr; 32(4):490-8. PubMed ID: 19672964
    [Abstract] [Full Text] [Related]

  • 24. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
    Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.
    Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.
    Park KS, Oh YL, Ki CS, Kim JW.
    J Mol Diagn; 2015 Jul; 17(4):431-7. PubMed ID: 25937618
    [Abstract] [Full Text] [Related]

  • 26. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [Abstract] [Full Text] [Related]

  • 27. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R.
    Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573
    [Abstract] [Full Text] [Related]

  • 28. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
    Chang H, Lee H, Yoon SO, Kim H, Kim A, Kim BH.
    Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961
    [Abstract] [Full Text] [Related]

  • 29. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y.
    Am Surg; 2024 Dec; 90(12):3209-3215. PubMed ID: 39047144
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z, Yang F, Zhang J, Lan Y, Li H, He R.
    Acta Cytol; 2023 Dec; 67(6):629-638. PubMed ID: 37708867
    [Abstract] [Full Text] [Related]

  • 31. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K.
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [Abstract] [Full Text] [Related]

  • 32. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
    Joo JY, Park JY, Yoon YH, Choi B, Kim JM, Jo YS, Shong M, Koo BS.
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
    [Abstract] [Full Text] [Related]

  • 33. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D.
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [Abstract] [Full Text] [Related]

  • 34. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A, Lin O, Tafe L, Ghossein R, Nafa K, Mitchell T, Ladanyi M, Arcila M.
    Acta Cytol; 2011 Aug; 55(6):563-9. PubMed ID: 22156467
    [Abstract] [Full Text] [Related]

  • 35. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C.
    Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
    [Abstract] [Full Text] [Related]

  • 36. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.
    Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV.
    Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068
    [Abstract] [Full Text] [Related]

  • 37. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.
    Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW.
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2867-72. PubMed ID: 15181070
    [Abstract] [Full Text] [Related]

  • 38. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 39. Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.
    Kim SK, Lee JH, Woo JW, Park I, Choe JH, Kim JH, Kim JS.
    Medicine (Baltimore); 2015 May; 94(21):e760. PubMed ID: 26020381
    [Abstract] [Full Text] [Related]

  • 40. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.